Fortress Biotech, Inc. - Mar 31, 2023 Form 4 Insider Report for Checkpoint Therapeutics, Inc. (CKPT)

Role
10%+ Owner
Signature
/s/ Samuel Berry, General Counsel and Authorized Agent
Stock symbol
CKPT
Transactions as of
Mar 31, 2023
Transactions value $
$0
Form type
4
Date filed
4/4/2023, 04:06 PM
Previous filing
Jan 6, 2023
Next filing
Jul 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CKPT COMMON STOCK, PAR VALUE $0.0001 Award $0 +35.7K +2.38% $0.00 1.54M Mar 31, 2023 Direct F1
transaction CKPT COMMON STOCK, PAR VALUE $0.0001 Award $0 +42.5K +2.76% $0.00 1.58M Apr 4, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Issuer is required to grant to the Reporting Person an equity fee in shares of the Issuer's Common Stock equal to 2.5% of the gross amount of any debt or equity financing consummated by the Issuer. These shares were granted by the Issuer to the Reporting Person following the closing of a financing.